修订后的白喉、破伤风和百日咳（DTP/DTaP/DT）疫苗信息资料——美国疾病控制与预防中心。通知。
Revised diphtheria, tetanus, and pertussis (DTP/DTaP/DT) vaccine information materials--CDC. Notice.
出版信息
Fed Regist. 1998 Jan 9;63(6):1730-3.
Under the National Childhood Vaccine Injury Act (42 U.S.C section 300aa-26), the CDC must develop vaccine information materials that health care providers, either public or private, are required to distribute to patients/parents prior to administration of each dose of specific vaccines. On September 13, 1996, CDC published a notice in the Federal Register (61 FR 48597) seeking public comment on proposed revision of the diphtheria, tetanus, and pertussis vaccine information materials to reflect Food and Drug Administration (FDA) licensure of acellular pertussis vaccine combined with diphtheria and tetanus toxoids (DTaP) for administration to infants as young as two months of age. The 60-day comment period ended on November 12, 1996. Following review of the comments submitted and consultation as required under the law, CDC has finalized the revised diphtheria, tetanus, and pertussis vaccine information materials. Those final materials are contained in this notice.
根据《国家儿童疫苗伤害法案》（美国法典第42编第300aa - 26条），疾病控制与预防中心（CDC）必须编制疫苗信息资料，要求无论是公立还是私立的医疗保健提供者在每次接种特定疫苗前向患者/家长发放。1996年9月13日，疾病控制与预防中心在《联邦公报》（第61卷，第48597页）上发布通知，就白喉、破伤风和百日咳疫苗信息资料的拟议修订征求公众意见，以反映美国食品药品监督管理局（FDA）对用于两个月龄婴儿接种的无细胞百日咳疫苗与白喉和破伤风类毒素联合疫苗（DTaP）的许可情况。60天的意见征求期于1996年11月12日结束。在审查了提交的意见并依法进行磋商后，疾病控制与预防中心最终确定了修订后的白喉、破伤风和百日咳疫苗信息资料。这些最终资料包含在本通知中。
Zotero 插件